BeatAML; an interview with Dr. De Gennaro...
This recent interview reminds me again why we’re all so pleased to be engaged in the Leukemia & Lymphoma Society's groundbreaking “BeatAML” clinical trial.
During the recent Atlantic Pulse Healthcare Conference in Boston, Dr. Lou De Gennaro, President and CEO of LLS participated in a conversation with New York Times columnist - and acute myeloid Leukemia (AML) survivor - Suleika Jaouad as part of AtlanticLIVE's conference, "Pulse: On the Front Lines of Health Care." They discussed LLS' BeatAML Master Trial and how LLS is leading the offensive against AML - by bringing the various players in the cancer ecosystem together to improve the standard of care for patients with this particularly deadly form of leukemia.